|1.||Garudadri, Chandrasekhar S: 1 article (01/2015)|
|2.||Senthil, Sirisha: 1 article (01/2015)|
|3.||Krishnamurthy, Rashmi: 1 article (01/2015)|
|4.||Lin, Lianjun: 1 article (01/2014)|
|5.||Wang, Yuchuan: 1 article (01/2014)|
|6.||Liu, Meilin: 1 article (01/2014)|
|7.||Chen, Yan: 1 article (01/2014)|
|8.||Meyer, David: 1 article (01/2013)|
|9.||Mohamed, Nabiel: 1 article (01/2013)|
|10.||Scardillo, Alessio: 1 article (01/2010)|
|1.||Ocular Hypertension (Glaucoma, Suspect)
02/01/1983 - "A dose-response study of the effect of levobunolol on ocular hypertension."
01/01/2014 - "Levobunolol hydrochloride solution is an effective therapy for ocular hypertension, probably by reducing aqueous fluid production. "
01/01/1990 - "The corneal endothelium was examined in ten patients suffering from ocular hypertension before, during and after four months of topical levobunolol treatment. "
01/01/1987 - "We evaluated the acute effects of installation of 0.5% levobunolol on aqueous humor dynamics in a double-masked study in 18 patients with ocular hypertension. "
02/01/1983 - "A single drop of placebo or levobunolol (at concentrations of 0.03%, 0.3%, 0.6%, 1%, and 2%) was administered to one eye of each of 48 patients with ocular hypertension. "
|2.||Open-Angle Glaucoma (Glaucoma, Open Angle)
01/01/1993 - "We treated both eyes of 38 African American patients who have stable open angle glaucoma with either levobunolol b.i.d. "
09/01/1982 - "Data from two short-term double-masked studies using 24 and 16 subjects suggest that topically applied levobunolol safely and effectively treats open-angle glaucoma and ocular hypertension. "
02/01/1988 - "The authors evaluated the efficacy of once-daily treatment with levobunolol in patients with primary open-angle glaucoma or ocular hypertension in an open-labeled, two-phase titration clinical trial. "
05/01/1992 - "Effects of a single instillation of levobunolol, a new nonselective beta-adrenoblocker, in normal subjects and patients with various forms of glaucoma were under study, as were the effects of prolonged administration of this drug in patients with open-angle glaucoma. "
05/01/2008 - "27 eyes of 27 patients were consecutively randomized to receive preserved or unpreserved levobunolol; all patients had a recent diagnosis of primary open angle glaucoma (POAG) or ocular hypertension and were not previously treated with topical medications. "
09/15/1992 - "In a randomized, double-masked, placebo-controlled study, we evaluated the effect of levobunolol 0.5%, a nonselective beta-blocker, on intraocular pressure, volume amplitude, and ocular pulsatile flow in healthy individuals and patients with glaucoma. "
05/01/1992 - "[Results of the clinical study of a new adrenergic beta blocker levobunolol hydrochloride in healthy subjects and in patients with glaucoma]."
09/01/1985 - "The results of these studies indicate that levobunolol is an effective therapy for the long-term treatment of glaucoma."
11/01/2003 - "A 72-year-old man with long-standing bilateral glaucoma became refractory to levobunolol ophthalmic solution therapy after many years. "
10/01/1992 - "Vistagan is a new beta-blocker produced by Allergan that is used for treatment of glaucoma. "
|4.||Contact Dermatitis (Eczema, Contact)
07/01/1999 - "Contact dermatitis from levobunolol eyedrops."
04/01/1997 - "Contact dermatitis due to levobunolol in eyedrops."
07/01/1995 - "Contact dermatitis from levobunolol and befunolol."
09/01/1989 - "A case is described in which, following local application of glaucoma eye drops containing Levobunolol, a recurring allergic contact eczema with periocular localisation occurred. "
12/01/2006 - "Contact dermatitis to levobunolol eyedrops superimposed on IgE-mediated rhinoconjunctivitis."
|5.||Allergic Contact Dermatitis
07/01/2006 - "Allergic contact dermatitis due to levobunolol in an ophthalmic preparation."
01/01/2007 - "Allergic contact dermatitis due to levobunolol with cross-sensitivity to befunolol."
07/01/1995 - "Allergic contact dermatitis from levobunolol eyedrops."
08/01/1995 - "Allergic contact dermatitis due to timolol and levobunolol in eyedrops, with no cross-sensitivity to other ophthalmic beta-blockers."
|3.||Ophthalmic Solutions (Eye Drops)
|10.||Carteolol (Carteolol Hydrochloride)